Liquid enzyme formulations
By storing the liquid enzyme preparation of the enzyme in a container after being replaced by inactive gas and adding specific additives, the problem of insufficient stability of the protein deamidase liquid enzyme preparation is solved, and the activity stability of the enzyme is significantly improved and the dissolved oxygen content is high. stable effect.
Patent Information
- Application Number
- CN202380039191.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-05-23
- Filing Date
- 2023-05-23
- Publication Date
- 2024-12-06
AI Technical Summary
In the prior art, liquid enzyme preparations for protein deamidase are insufficient in terms of stability, especially the stability of transglutaminase is low in low pH environments, and the liquid enzyme preparations for protein deamidase are lacking. Research.
By storing the liquid enzyme preparation of the enzyme in a container after the internal space is replaced by inactive gas, and adding specific additives, such as sugar alcohol, glycerol, lecithin, etc. to the liquid enzyme preparation, the activity stability of the enzyme is significantly improved .
The activity stability of the enzyme has been significantly improved, especially under high dissolved oxygen conditions, and the additives used can effectively improve the stability of protein deamidase, surpassing the effects of traditional antioxidants.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to a liquid enzyme preparation, and more particularly to a liquid enzyme preparation having excellent enzyme activity stability. Background Art
[0002] As a target for glutamine and asparagine residues in proteins c -amide and β Enzymes that deamidate -amide groups are known, such as those described in Patent Document 1, for example, protein glutaminase derived from Chryseobacterium gleum JCM2410 strain and protein glutaminase derived from Chryseobacterium proteolyticum 9670 strain. Such protein deamidase enzyme preparations are currently commercially available only in powder form.
[0003] Regarding enzyme preparations, in general, if dust removal and handling are taken into consideration, liquid form is preferred over powder form. Therefore, various enzymes are studied for the technology of formulating enzyme preparations in liquid form. For example, Patent Document 2 proposes a liquid enzyme preparation characterized in that at least one milk protein cross-linking and / or modifying enzyme is contained in a polyol-water suspension, wherein the polyol-water suspension contains 25% to 100% (w / w) of polyol and has a pH value in the range of 4.4 to 5.1. Specifically, Patent Document 2 found that the stability of transglutaminase at pH 5.2 is low. Based on this finding, the stability of transglutaminase preparations in glycerol-water suspensions at pH 4.4 to 4.8 and transglutaminase preparations in sorbitol-water suspensions at pH 4.6 is improved. At the same time, tyrosinase preparations in glycerol-water suspensions at pH 4.6 and protein glutaminase preparations in glycerol-water suspensions at pH 4.6 are also disclosed.
[0004] Patent Document 3 describes that a useful protein composition including a useful protein, a solvent, and a compound having a thiol structure can be prepared by bubbling an asphyxiating gas such as nitrogen to adjust the dissolved oxygen concentration to 3 mg / L or less, thereby producing a stable useful protein composition such as interferon.
[0005] Prior art literature
[0006] Patent Literature Patent Document 1: International Publication No. 2010 / 029685 Patent Document 2: International Publication No. 2013 / 064736 Patent Document 3: Japanese Patent Application Publication No. 2013-049650 Summary of the invention
[0007] Technical problem to be solved by the invention Patent Document 2 studies the stability of a liquid enzyme preparation of a transglutaminase preparation, but only discloses a formulation of a liquid enzyme preparation of a protein deamidase, and does not fully study the stability of the enzyme. c On the other hand, there is no mention of liquid enzyme preparations of protein deamidase, and certainly no studies have been conducted.
[0008] Therefore, an object of the present invention is to provide a liquid enzyme preparation having excellent activity stability of an enzyme such as protein deamidase.
[0009] Technical solutions for solving technical problems The inventors have conducted in-depth research and found that by accommodating a liquid enzyme preparation containing an enzyme in a container after the internal space is replaced by an inert gas, the activity stability of the enzyme is significantly improved. This effect can also be obtained when the dissolved oxygen content in the liquid preparation is more than 3 mg / L, which shows that the stability of the useful protein is reduced in Patent Document 3. Therefore, the liquid enzyme preparation containing the enzyme is independent of the dissolved oxygen content, and such an effect can be obtained only by replacing the internal space with an inert gas, which is completely unexpected.
[0010] Furthermore, the present inventors have found that by adding a predetermined additive to a liquid enzyme preparation containing protein deamidase, the activity stability of protein deamidase is also improved. Since this effect cannot be obtained when using other various ingredients known as antioxidants such as ascorbic acid, it is found that this effect is a unique effect brought about by the use of the predetermined additive.
[0011] The present invention has been completed based on these findings. That is, the present invention includes the inventions disclosed below.
[0012] Item 1. A liquid enzyme preparation, characterized in that the liquid enzyme preparation contains an enzyme and is contained in a container whose internal space is replaced with an inert gas (hereinafter also referred to as a "first liquid enzyme preparation").
[0013] Item 2. The liquid enzyme preparation according to Item 1, wherein the enzyme is protein deamidase or transglutaminase.
[0014] Item 3. The liquid enzyme preparation according to Item 1 or 2, wherein the enzyme activity is 0.1 U / ml to 10000 U / ml.
[0015] Item 4. A liquid enzyme preparation according to any one of Items 1 to 3, wherein the liquid enzyme preparation contains an additive selected from sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrates, polyphosphates, tartrates, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
[0016] Item 5. A liquid enzyme preparation (hereinafter also referred to as "second liquid enzyme preparation"), characterized in that the liquid enzyme preparation contains protein deamidase and an additive, and the additive is selected from sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrate, polyphosphate, tartrate, phytic acid, metaphosphoric acid, sodium chloride, tocotrienol, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
[0017] Item 6. The liquid enzyme preparation according to Item 4 or 5, wherein the total amount of the additive is 5 w / v% or more.
[0018] Item 7. The liquid enzyme preparation according to any one of Items 4 to 6, wherein the total amount of the additive is 80 w / v% or less.
[0019] Item 8. The liquid enzyme preparation according to any one of Items 1 to 7, wherein the pH of the liquid enzyme preparation is 5.5 or higher.
[0020] Item 9. The liquid enzyme preparation according to any one of Items 1 to 8, wherein the pH of the liquid enzyme preparation is 8.2 or less.
[0021] Item 10. The liquid enzyme preparation according to any one of Items 5 to 9, wherein the protein deamidase activity is 0.1 U / ml to 10000 U / ml.
[0022] Item 11. The liquid enzyme preparation according to any one of Items 2 to 10, wherein the protein deamidase is derived from Chryseobacterium proteolyticus.
[0023] Item 12. A method for stabilizing the enzyme activity of a liquid enzyme preparation, comprising: storing the liquid enzyme preparation containing the enzyme in a container whose internal space is replaced with an inert gas.
[0024] Item 13. A protein deamidase activity stabilizer for a liquid enzyme preparation containing protein deamidase, characterized in that it contains an additive selected from sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrate, polyphosphates, tartrates, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
[0025] Effects of the Invention According to the present invention, a liquid enzyme preparation having excellent enzyme activity stability is provided. DETAILED DESCRIPTION
[0026] [1.Liquid enzyme preparation] The first liquid enzyme preparation of the present invention is characterized in that it comprises enzyme and is contained in a container after the inner space is replaced by an inert gas. In addition, the second liquid enzyme preparation of the present invention is characterized in that it comprises protein deamidase and additives, and the above-mentioned additives are selected from sugar alcohols, glycerol, ethanol, sulfite, lecithin, citrate, polyphosphate, tartrate, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole. Hereinafter, the first liquid enzyme preparation of the present invention and the second liquid enzyme preparation (these first liquid enzyme preparation and the second liquid enzyme preparation are collectively referred to as liquid enzyme preparations) are described in detail.
[0027] [1-1. Enzyme] The enzyme contained in the first liquid enzyme preparation of the present invention is not particularly limited. Preferred enzymes include protein deamidase and transglutaminase, and protein deamidase is particularly preferred. The enzyme contained in the second liquid enzyme preparation of the present invention is protein deamidase.
[0028] [Protein deamidase] Protein deamidase is an enzyme that shows the effect of decomposing the amide-containing side chain of protein without peptide bond cleavage and protein cross-linking, and its type and source are not particularly limited. In addition, as long as the above-mentioned effect is the main activity, it may further have the effect of decomposing the amide-containing side chain of protein accompanied by peptide bond cleavage and protein cross-linking. As examples of protein deamidase, there can be cited enzymes that deamidate glutamine residues in proteins and convert them into glutamic acid (e.g., protein glutaminase), and enzymes that deamidate asparagine residues in proteins and convert them into aspartic acid (e.g., protein asparaginase). More specific examples of protein deamidase include protein deamidase derived from Chryseobacterium, Flavobacterium, Empedobacter, Sphingobacterium, Aureobacterium, or Myroides as disclosed in JP2000-50887A, JP2001-218590A, and WO2006 / 075772A1; protein deamidase derived from Luteimicrobium, Agromyces, Microbacterium, or Leifsonia as disclosed in WO2015 / 133590; and commercially available protein glutaminase derived from Chryseobacterium. These protein deamidase may be used alone or in combination of a plurality of them.
[0029] Among these protein deaminases, from the viewpoint of producing a liquid enzyme preparation having better activity stability, preferably, a protein deamidase derived from the genus Chryseobacterium is used, more preferably, a protein glutaminase derived from the genus Chryseobacterium is used, and further preferably, a protein glutaminase derived from the genus Chryseobacterium proteolyticus is used.
[0030] Protein deamidase can be prepared from the culture fluid of the microorganism that becomes the source of the above-mentioned protein deamidase. As a specific preparation method, a method for recovering protein deamidase from the culture fluid or bacterial cell of the above-mentioned microorganism can be cited. For example, when using a protein deamidase secretory microorganism, the enzyme can be separated and / or purified after the bacterial cell is recovered from the culture fluid by filtering, centrifugation, etc. as needed. In addition, when using a protein deamidase non-secreting microorganism, the enzyme can be separated and / or purified after the bacterial cell is recovered from the culture fluid in advance as needed, and the enzyme is exposed by crushing the bacterial cell by pressure treatment, ultrasonic treatment, etc. As the separation and / or purification method of the enzyme, known protein separation and / or purification methods can be used without particular limitation, for example, various chromatography methods such as centrifugation, UF concentration method, salting-out method, and ion exchange resin can be cited.
[0031] The content of the protein deamidase in the liquid enzyme preparation of the present invention is not particularly limited as long as it is an amount at which the protein deamidase can effectively exert its effect during use of the liquid enzyme preparation, and examples thereof include 0.1 U / mL to 10,000 U / mL, 1 U / mL to 5,000 U / mL, 10 U / mL to 3,000 U / mL, or 50 U / mL to 2,000 U / mL, preferably 100 U / mL to 1,500 U / mL, more preferably 200 U / mL to 1,000 U / mL, further preferably 300 U / mL to 900 U / mL, or 500 U / mL to 800 U / mL, and further preferably 600 U / mL to 700 U / mL.
[0032] Regarding the activity of protein deamidase, benzyloxycarbonyl-L-glutamine glycine (Z-Gln-Gly) was used as substrate and 1 m The amount of enzyme per mol of ammonia is taken as 1 unit (1U).
[0033] [Transglutaminase] Transglutaminase is an enzyme that catalyzes the cleavage of glutamine residues in proteins. c -Carboxyamide groups and lysine residues e -amino group to cross-link proteins (EC 2.3.2.13), and its type and origin are not particularly limited. Examples of transglutaminases include calcium-dependent transglutaminases that require calcium for activity and calcium-independent transglutaminases that do not require calcium for activity.
[0034] Specific examples of transglutaminases used in the present invention are not particularly limited. Specifically, transglutaminases derived from microorganisms can be cited, and specifically, transglutaminases derived from the genus Streptomyces such as Streptomyces ladakanum, Streptomyces cinnamoneus, Streptomyces griseocarneus, Streptomyces lavendulae, or Streptomyces lydicus (for example, refer to Japanese Patent Application Laid-Open No. 64-27471), transglutaminases derived from the genus Kutzneria such as Kutzneria albida (for example, refer to Japanese Patent Application Laid-Open No. 2020-195397), and transglutaminases derived from the genus Longimycelium can be cited. tulufanense) and other transglutaminases derived from the genus Longimycelium; transglutaminases derived from mammals (for example, see Japanese Patent Publication No. 1-50382); transglutaminases derived from fish (for example, see Japanese Patent Publication No. 06-113844); recombinant (recombinant) transglutaminases obtained by recombinant DNA technology (for example, see Japanese Patent Publication No. 5-199883 and Japanese Patent Publication No. 2004-97099); transglutaminases having a structure in which the pre-sequence peptide of transglutaminase is combined with mature transglutaminase (for example, see International Publication No. 2009 / 101762), etc. These transglutaminases may be used alone or in combination of two or more.
[0035] Among these transglutaminases, from the viewpoint of further improving the stabilization effect, preferably, a transglutaminase derived from a microorganism is used, more preferably, a transglutaminase derived from the genus Streptomyces is used, and even more preferably, a transglutaminase derived from the species Streptomyces mobaraensis is used.
[0036] The content of transglutaminase in the first liquid enzyme preparation of the present invention is not particularly limited as long as it is a degree that can effectively exert the effect of transglutaminase during use of the liquid enzyme preparation. For example, it can be 1 U / mL to 100,000 U / mL, preferably 10 U / mL to 50,000 U / mL, more preferably 90 U / mL to 10,000 U / mL, further preferably 180 U / mL to 5,000 U / mL, 280 U / mL to 3,000 U / mL, or 380 U / mL to 1,500 U / mL, further preferably 480 U / mL to 1,000 U / mL, 490 U / mL to 800 U / mL, or 500 U / mL to 700 U / mL.
[0037] In addition, the activity value of transglutaminase is calculated by converting the amount of transglutaminase produced in one minute into 1 m The enzyme activity of 1 mol of hydroxamic acid was set as 1 unit (U).
[0038] [1-2. Specified additives] The second liquid enzyme preparation of the present invention contains a predetermined additive from the viewpoint of obtaining a liquid enzyme preparation with better activity stability. In addition, the first liquid enzyme preparation of the present invention may also contain the predetermined additive.
[0039] The prescribed additives in the liquid enzyme preparation of the present invention are selected from sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrates, polyphosphates, tartrates, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, betaine, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
[0040] Examples of the sugar alcohol include sorbitol, xylitol, maltitol, etc. These sugar alcohols may be used alone or in combination of two or more.
[0041] As for the above-mentioned sulfites, citrates, polyphosphates and tartrates, preferably, alkali metal salts such as potassium salts and sodium salts are used, and more preferably, sodium salts are used.
[0042] As the above-mentioned lecithin, natural lecithin such as soybean lecithin, sunflower lecithin, rapeseed lecithin, egg yolk lecithin, enzyme-treated lecithin (lecithin with phosphatidylglycerol obtained from the above-mentioned natural lecithin as the main component), enzyme-decomposed lecithin (lecithin with phosphatidic acid and lysolecithin obtained from the above-mentioned natural lecithin as the main components), and fractionated lecithin (lecithin with sphingomyelin, phosphatidylinositol, phosphatidylethanolamine and phosphatidylcholine obtained from the above-mentioned natural lecithin as the main components) can be mentioned. These lecithins can be used alone or in combination. Among these lecithins, soybean lecithin, sunflower lecithin, and rapeseed lecithin are preferably mentioned from the viewpoint of further improving the activity stability of the enzyme in the liquid enzyme preparation contacted with the gas phase not replaced by the inert gas.
[0043] Examples of the tocotrienols include α -Tocotrienols, c -Tocotrienols, d -Tocotrienol. These tocotrienols may be used alone or in combination. Among these tocotrienols, from the viewpoint of further improving the activity stability of the enzyme in the liquid enzyme preparation in contact with the gas phase that has not been replaced by the inert gas, preferably α -Tocotrienols, c -Tocotrienols and d - Tocotrienol mixtures. In the blending of tocotrienols, from the viewpoint of further improving the activity stability of the enzyme in the liquid enzyme preparation in contact with the gas phase that has not been replaced with the inert gas, it is preferable to use a rice bran oil extract represented by Oryza tocotrienol.
[0044] The pectin is not particularly limited. Specific examples of pectin include pectin derived from sugar beet, citrus, apple, etc., and preferably pectin derived from sugar beet is used from the viewpoint of further improving the activity stability of the enzyme in the liquid enzyme preparation in contact with the gas phase that is not replaced by the inert gas.
[0045] The content of the additive of the regulation in the liquid enzyme preparation of the present invention is not particularly limited, but in total amount, for example, 5w / v% or more can be cited, preferably 8w / v% or more, 15w / v% or more, 20w / v% or more, 25w / v% or more, 30w / v% or more, 35w / v% or more, 40w / v% or more, 50w / v% or more, 60w / v% or more, or 70w / v% or more. In addition, the upper limit of the content of the additive of regulation is not particularly limited either, in total amount, for example, 80w / v% or less, 75w / v% or less, 65w / v% or less, 55w / v% or less, 45w / v% or less, 35w / v% or less, 25w / v% or less, 20w / v% or less, or 15w / v% or less can be cited. As the content of the prescribed additive per 1U enzyme in the liquid enzyme preparation of the present invention, in total, for example, 0.075 mg or more can be cited, preferably 0.1 mg or more, 0.2 mg or more, 0.3 mg or more, 0.4 mg or more, 0.45 mg or more, 0.5 mg or more, 0.6 mg or more, 0.75 mg or more, 0.9 mg or more or 1 mg or more. The upper limit of the content of the prescribed additive per 1U enzyme in the liquid enzyme preparation of the present invention is not particularly limited either, and in total, 5 mg or less, 4 mg or less, 3 mg or less, 2 mg or less, 1.5 mg or less, 1.2 mg or less, 1.1 mg or less, 1 mg or less, 0.85 mg or less, 0.7 mg or less, 0.55 mg or less, 0.4 mg or less, 0.35 mg or less or 0.3 mg or less can be cited.
[0046] In the case of including any one component selected from sugar alcohol and glycerol as a prescribed additive, as the content of each component, for example, 10w / v% or more, 15w / v% or more, 20w / v% or more, 25w / v% or more, or 30w / v% or more can be cited, preferably 35w / v% or more, or 40w / v% or more, more preferably 50w / v% or more, further preferably 60w / v% or more, and further preferably 70w / v% or more. In this case, the upper limit of the content range of each component is not particularly limited, for example, 80w / v% or less, 75w / v% or less, 65w / v% or less, 55w / v% or less, 45w / v% or less, 35w / v% or less, 25w / v% or less, 20w / v% or less or 15w / v% or less can be cited. As the content of each component selected from sugar alcohol and glycerol per 1U enzyme in the liquid enzyme preparation of the present invention, for example, more than 0.15mg, more than 0.2mg, more than 0.3mg, more than 0.4mg or more than 0.45mg can be cited, preferably more than 0.5mg or more than 0.6mg, more preferably more than 0.75mg, more preferably more than 0.9mg, and more preferably more than 1mg. In addition, as the upper limit of the content range of each component selected from sugar alcohol and glycerol per 1U enzyme in the liquid enzyme preparation of the present invention, there is no particular limitation, for example, less than 5mg, less than 4mg, less than 3mg, less than 2mg, less than 1.5mg, less than 1.2mg, less than 1.1mg, less than 1mg, less than 0.85mg, less than 0.7mg, less than 0.55mg, less than 0.4mg, less than 0.35mg or less than 0.3mg can be cited. When two or more components selected from sugar alcohols and glycerol are contained in combination, these components can be contained in the liquid enzyme preparation of the present invention so that the total amount thereof becomes the above-mentioned content (the amount shown as the content of each of the components selected from sugar alcohols and glycerol).
[0047] When sulfite, lecithin, polyphosphate, phytic acid, metaphosphoric acid, tocotrienol, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and / or butylated hydroxyanisole are contained as the prescribed additive, the content of each of these components may be, for example, 0.01 w / v% or more, preferably 0.03 w / v% or more, more preferably 0.05 w / v% or more, 0.1 w / v% or more, 0.2 w / v% or more, 0.4 w / v% or more, 0.6 w / v% or more, 0.8 w / v% or more, 1 w / v% or more, 1.5 w / v% or more, or 2 w / v% or more. In this case, the upper limit of the content range of each of these components is not particularly limited, for example, 12w / v% or less can be cited, preferably 10w / v% or less, more preferably 6w / v% or less, 4w / v% or less, 3w / v% or less, 2w / v% or less, or 1w / v% or less. As the content of each of these components per 1U enzyme in the liquid enzyme preparation of the present invention, for example, 0.00005mg or more can be cited, preferably 0.0001mg or more, more preferably 0.0005mg or more, further preferably 0.00075mg or more, more preferably 0.001mg or more or 0.0012mg or more. As the upper limit of the content range of each of these components per 1U enzyme in the liquid enzyme preparation of the present invention, it is not particularly limited, for example, 2.5mg or less, 2mg or less, 1.5mg or less, 1mg or less, 0.75mg or less, 0.5mg or less, 0.25mg or less, 0.2mg or less or 0.175mg or less can be cited. In addition, when a combination of two or more of sulfites, lecithin, polyphosphates, phytic acid, metaphosphoric acid, tocotrienols, methionine, pectin, betaine, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole is contained, they can be contained in the liquid enzyme preparation of the present invention in such a manner that their total amount becomes the above-mentioned content (the amount shown as their respective contents).
[0048] In the case of containing ethanol, citrate, tartrate and / or sodium chloride as a prescribed additive, as the content of each of these components, for example, more than 0.5w / v% can be cited, preferably more than 0.8w / v%, more preferably more than 2.5w / v%, further preferably more than 4.5w / v%, more than 6w / v%, more than 8w / v%, more than 9w / v%, more than 12w / v%, or more than 14w / v%. In this case, the upper limit of the content range of each of these components is not particularly limited, for example, less than 20w / v%, less than 18w / v%, less than 16w / v%, less than 13w / v%, less than 11w / v%, less than 9w / v%, less than 7w / v% or less than 6w / v%. As the content of each of these components per 1U enzyme in the liquid enzyme preparation of the present invention, for example, more than 0.0075mg can be cited, preferably more than 0.012mg, more preferably more than 0.037mg, further preferably more than 0.068mg, more than 0.09mg, more than 0.12mg, more than 0.14mg, more than 0.18mg or more than 0.2mg. As the upper limit of the content range of each of these components per 1U enzyme in the liquid enzyme preparation of the present invention, there is no particular limitation, for example, less than 0.3mg, less than 0.27mg, less than 0.24mg, less than 0.2mg, less than 0.16mg, less than 0.14mg, less than 0.1mg or less than 0.09mg can be cited. In addition, in the case of a combination of two or more of ethanol, citrate, tartrate and sodium chloride, it is possible to be included in the liquid enzyme preparation of the present invention in a manner such that their total amount becomes the above-mentioned content (the amount shown as their respective content).
[0049] [1-3. Other ingredients] The liquid enzyme preparation of the present invention may contain or not contain other components, except for the above enzyme and the prescribed additives, to the extent that the effect of the present invention is not affected. As these other components, buffers, other enzymes, other additives other than the above prescribed additives, etc. may be enumerated.
[0050] Examples of other enzymes include amylase ( α -Amylase, β -amylase, glucoamylase), glucosidase ( α -Glucosidase, β -glucosidase), galactosidase ( α -galactosidase, β-galactosidase), peptidase (leucine peptidase, aminopeptidase), lipase, esterase, cellulase, phosphatase (acid phosphatase, alkaline phosphatase), nuclease, deaminase, oxidase, dehydrogenase, glutaminase, pectinase, catalase, glucanase, transglutaminase, pullulanase, etc. These other enzymes may be contained alone or in combination of multiple types.
[0051] As other additives, buffers, suspending agents, physiological saline, etc. can be mentioned. As buffers, for example, phosphate buffers, acetic acid buffers, and citric acid buffers can be mentioned. These other additives can be included alone or in combination of multiple types.
[0052] [1-4. Preparation form, etc.] The liquid enzyme preparation of the present invention is a liquid preparation. The liquid enzyme preparation of the present invention can be prepared by adding a predetermined amount of enzyme and a predetermined additive and other components formulated as required to water, or removing unnecessary components such as mixed polymers from the culture solution of the enzyme-producing strain by separation and / or purification, adding a predetermined additive and other components formulated as required, and then sterilizing as required.
[0053] The pH of the liquid enzyme preparation of the present invention (referring to the pH at 25° C., the same below) is not particularly limited, and for example, it can be 5.5 or more, preferably 5.8 or more. The upper limit of the pH range of the liquid enzyme preparation of the present invention is not particularly limited, and is preferably 8.2 or less, more preferably 7.5 or less, further preferably 7 or less, and further preferably 6.5 or less.
[0054] [1-5. Dissolved oxygen content] There is no particular limitation on the dissolved oxygen amount contained in the liquid enzyme preparation of the present invention. In particular, about the first liquid enzyme preparation of the present invention, due to the excellent activity stability of the enzyme, even if the dissolved oxygen amount contained in the first liquid enzyme preparation is not actively reduced, the activity stabilization effect can be effectively obtained. From such a viewpoint, as a preferred example of the dissolved oxygen amount in the first liquid enzyme preparation, more than 3mg / L can be cited, preferably more than 4mg / L, more preferably more than 4.5mg / L, more preferably more than 5mg / L. As the upper limit of the dissolved oxygen amount range in the first liquid enzyme preparation, there is no particular limitation, for example, less than 8mg / L can be cited, preferably less than 7mg / L, more preferably less than 6mg / L, more preferably less than 5.5mg / L. It should be noted that the dissolved oxygen amount contained in the second liquid enzyme preparation of the present invention can also be applied to the dissolved oxygen amount in the above-mentioned first liquid enzyme preparation. In addition, the liquid enzyme preparation of the present invention does not exclude the situation that the dissolved oxygen amount is less than 3mg / L.
[0055] [1-6. Storage in containers] The liquid enzyme preparation of the present invention is suitably contained in a container capable of containing liquid. The first liquid enzyme preparation of the present invention is contained in a container whose inner space is replaced by an inert gas. As the inert gas, there is no particular limitation, and for example, nitrogen and rare gases (helium, argon, etc.) can be cited. There is no particular limitation on the method for replacing the inner space of the container with an inert gas, and for example, a method in which a gaseous inert gas or a liquid inert gas is directly added to the container can be cited.
[0056] Even if the first liquid enzyme preparation of the present invention does not allow the inert gas to be bubbled in the liquid enzyme preparation, the activity stability of the enzyme can be improved by being accommodated in a container whose inner space is replaced by the inert gas. Therefore, in a preferred embodiment of the first liquid enzyme preparation of the present invention, the inert gas is not bubbled. It should be noted that the first liquid enzyme preparation of the present invention does not exclude the mode of bubbling the inert gas.
[0057] In the first liquid enzyme preparation of the present invention contained in the above-mentioned container, the oxygen concentration in the container (i.e., in the gas phase replaced by the inert gas in the container) is, for example, 5 v / v% or less, preferably 3 v / v% or less, more preferably 2 v / v% or less, 1.5 v / v% or less, 1.3 v / v% or less, or 1 v / v% or less. The lower limit of the oxygen concentration in the container is not particularly limited, but, for example, 0.01 v / v% or more, 0.05 v / v% or more, 0.1 v / v% or more, 0.4 v / v% or more, 0.6 v / v% or more, 0.8 v / v% or more, or 1 v / v% or more can be mentioned.
[0058] The first liquid enzyme preparation of the present invention is contained in a container whose internal space is replaced by an inert gas, and as described above, it exerts an excellent enzyme activity stabilization effect. Furthermore, when the first liquid enzyme preparation is opened during use and comes into contact with a gas phase that is not replaced by an inert gas, it becomes a second liquid enzyme preparation, and exerts the enzyme activity stabilization effect brought about by the prescribed additive.
[0059] [1-7. Application] The liquid enzyme preparation of the present invention can be used for any purpose that utilizes the activity of the enzyme. For example, the liquid enzyme preparation of the present invention can be used for the purpose of modifying proteins. There is no particular limitation on the specific method of modifying proteins. For example, when protein deamidase is included as the enzyme, as long as the glutamine residues and asparagine residues of the protein are degraded, the liquid enzyme preparation of the present invention can be used for any purpose that utilizes the activity of the enzyme. For example, the liquid enzyme preparation of the present invention can be used for the purpose of modifying proteins. c -amide and β The deamidation of the amide group to generate a carboxyl group may change the properties of the protein. Specifically, examples of protein modification include an increase in protein solubility, an increase in water dispersibility, an improvement in emulsification ability, and an improvement in emulsion stability.
[0060] Therefore, the liquid enzyme preparation of the present invention can be widely used in the field of food. Specifically, the use of improving the solubility, dispersibility, emulsification, etc. of animal protein and / or plant protein in a weakly acidic environment in the pH range of common food (for example, the production of acidic beverages such as coffee creamer and juice, seasonings, mayonnaise, and cream); increasing the solubility and dispersibility of poorly soluble plant protein (for example, the production of tempura powder using wheat gluten); modifying the dough in bread and dessert making (for example, the production of crackers, biscuits, cookies, pizza or pie crust); removing or reducing allergens in allergenic proteins in food (for example, For example, the manufacture of food for wheat allergy patients); the manufacture of products for reducing the mineral sensitivity of proteins, increasing the soluble mineral content in a liquid containing proteins and minerals, and improving the absorbability of minerals into the human body (for example, beverages containing high minerals (such as calcium), and the manufacture of mineral (such as calcium) absorption enhancers); the manufacture of products for reducing bitterness, increasing the protein decomposition rate of proteases, and / or increasing the glutamic acid content (for example, amino acid seasonings (hydrolyzates of animal proteins (HAP), hydrolyzates of vegetable proteins (HVP)), miso and soy sauce), etc.
[0061] [2. Method for stabilizing enzyme activity of liquid enzyme preparation and stabilizer for protein deamidase activity of liquid enzyme preparation] Regarding the first liquid enzyme preparation, as described above, by storing the liquid enzyme preparation containing the enzyme in a container whose internal space is replaced by an inert gas, the stability of the enzyme activity can be improved. Therefore, the present invention also provides a method for stabilizing the enzyme activity of a liquid enzyme preparation, which comprises: storing the liquid enzyme preparation containing the enzyme in a container whose internal space is replaced by an inert gas.
[0062] In addition, regarding the second liquid enzyme preparation, as described above, by adding a prescribed additive to the liquid enzyme preparation containing protein deamidase, the stability of protein deamidase activity can be improved. Therefore, the present invention also provides a protein deamidase activity stabilizer for a liquid enzyme preparation containing protein deamidase, which comprises an additive selected from sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrate, polyphosphate, tartrate, phytic acid, metaphosphoric acid, sodium chloride, tocotrienol, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
[0063] In the method for stabilizing enzyme activity of a liquid enzyme preparation and the stabilizer for protein deamidase activity of a liquid enzyme preparation of the present invention, the types and usage amounts of each component are as shown in the above-mentioned "1. Liquid enzyme preparation".
[0064] Example Hereinafter, the present invention will be specifically described by way of examples, but the present invention is not limited to these examples.
[0065] The details of each component used in the following test examples are as follows.
[0066] Soy lecithin: lecithin, derived from soybeans (Fujifilm Wako Pure Chemical Industries, Ltd.) ·Sunflower lecithin: SLP-PASTE SF (Tsuji Oil) · Rapeseed lecithin: SLP-Rapeseed paste lecithin preparation (Tsuji Oil) ·Tocotrienols: Oryza Tocotrienols (Oryza Oil Chemical Co., Ltd.) · Pectin: Sugar beet pectin ·Chili pigment: PapriX powder (Glico Nutrition Foods Co., Ltd.) Rosemary extract: Ethanol soluble fraction of Rosemary extract 50% (Vidya Herbs Pvt. Ltd.) · Tocopherol and tea extract: Super Emulsion TSM-09 (Taiyo Chemical Co., Ltd.) BHA: Butylated Hydroxyanisole [Test Example 1] Insoluble components such as impurity polymers were removed from the culture solution of Chryseobacterium utilis, which is a protein glutaminase producing strain, and purified by ion exchange chromatography. Then, the pH was adjusted to 6.0 (25° C.) using 80% acetic acid or 6N sodium hydroxide aqueous solution as a pH adjuster to prepare a liquid enzyme preparation having a concentration of protein glutaminase (PG) as a protein deamidase as shown in Table 1. The prepared liquid enzyme preparation was placed in a container, and nitrogen was injected into the gas phase (including the space above the liquid phase of the liquid enzyme preparation) of the storage container using a nitrogen cylinder. The process of taking out and putting in the container was repeated 20 times, and the oxygen in the container was replaced with nitrogen and sealed to obtain a liquid enzyme preparation in the container (Example 1-1). In addition, a liquid enzyme preparation in the container was obtained in the same manner except that the oxygen in the container was not replaced with nitrogen (Comparative Example 1-1).
[0067] The liquid enzyme preparation thus obtained and placed in a container was left to stand under the storage conditions described in Table 1. The protein deamidase activity values before and after standing were measured by the following method.
[0068] 0.1 mL of a sample solution containing protein deamidase was added to 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly, and the mixture was allowed to stand at 37°C for 10 minutes, followed by the addition of 1 mL of 0.4 M TCA solution to stop the reaction. As a blank, 1 mL of a 0.4 M TCA solution was added to 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly, and 0.1 mL of a sample solution containing protein deamidase was further added, followed by the addition of 1 mL of the solution, and the mixture was allowed to stand at 37°C for 10 minutes.
[0069] The amount of ammonia generated in the reaction solution was measured using Ammonia-test Wako (Fujifilm Wako Pure Chemical Industries, Ltd.). The ammonia concentration in the reaction solution was determined from a calibration curve showing the relationship between ammonia concentration and absorbance (630 nm) prepared using an ammonia standard solution (ammonium chloride).
[0070] Will generate 1 in 1 minute m The activity of protein deamidase was calculated by the following formula, with the amount of enzyme per mol of ammonia as 1 unit (1U). In the formula, the amount of reaction solution is 2.1, the amount of enzyme solution is 0.1, and Df is the dilution ratio of the enzyme solution. In addition, 17.03 is the molecular weight of ammonia.
[0071] [Number 1] Protein deamidase activity (U / mL) = ammonia concentration in reaction solution (mg / L) × (1 / 17.03) × (reaction solution volume / enzyme solution volume) × (1 / 10) × Df The relative value (%) of the protein deamidase activity value after standing was calculated as the residual activity, with the protein deamidase activity value before standing being 100%.
[0072] [Table 1]
[0073] As shown in the table above, by simply storing the liquid enzyme preparation containing protein deamidase in a container whose internal space has been replaced with an inert gas, the activity stability of the protein deamidase is significantly improved despite the high dissolved oxygen concentration in the liquid enzyme preparation. It should be noted that if the storage period at 40°C is further extended and the residual activity is measured at the time of 2 months, it is only 9% in Comparative Example 1-1, while Example 1-1 can also maintain 88%.
[0074] [Test Example 2] The residual activity was measured in the same manner as in Test Example 1 except that the composition of the liquid enzyme preparation, whether the internal space of the container storing the liquid enzyme preparation was replaced with nitrogen, and the storage conditions were as shown in Tables 2A to 2D. The results are shown in Tables 2A to 2D.
[0075] [Table 2A]
[0076] [Table 2B]
[0077] [Table 2C]
[0078] [Table 2D]
[0079] As shown in the above table, the liquid enzyme preparation containing protein deamidase contained in the container whose internal space was replaced with an inert gas achieved significantly high enzyme activity stability.
[0080] [Test Example 3] Insoluble components such as polymers were removed from the culture solution of Streptomyces mobara, which is a transglutaminase-producing strain, and the pH was adjusted to 6.0 (25°C) using 80% acetic acid or 6N-sodium hydroxide aqueous solution as a pH adjuster to prepare a liquid enzyme preparation having a transglutaminase concentration as shown in Table 3. The prepared liquid enzyme preparation was placed in a container, and nitrogen was injected into the gas phase of the storage container (the space above the liquid phase of the liquid enzyme preparation) using a nitrogen bottle, and the process was repeated 20 times to replace the oxygen in the container with nitrogen and seal it to obtain a liquid enzyme preparation in the container (Examples 1-18 to 1-21). In addition, liquid enzyme preparations in the container were obtained in the same manner except that the oxygen in the container was not replaced with nitrogen (Comparative Examples 1-18 to 1-21).
[0081] The liquid enzyme preparation thus obtained and packed in a container was allowed to stand for 6 months at 25° C. The transglutaminase activity values before and after the standing were measured by the following method.
[0082] <Transglutaminase Activity Assay Method> The enzyme activity of transglutaminase was measured by the method described below using benzyloxycarbonyl-L-glutamine glycine and hydroxylamine as substrates.
[0083] A substrate solution was prepared by dissolving 2.42 g of 2-amino-2-hydroxymethyl-1,3-propanediol, 0.70 g of hydroxylammonium hydrochloride, 0.31 g of reduced glutathione, and 1.01 g of Z-Gln-Gly (benzyloxycarbonyl-L-glutamine glycine) in distilled water to a total volume of 100 mL (pH 6.0).
[0084] A color developing solution was prepared by mixing 30 mL of a 3 M hydrochloric acid solution, 30 mL of a 12 wt % trichloroacetic acid solution, and 30 mL of a 5 wt % iron (III) chloride solution.
[0085] The enzyme was diluted to an appropriate concentration using 200 mM MES buffer (pH 6.0) to prepare a sample solution.
[0086] In 10 m Add 100 L of sample solution and mix m After adding 100 L of substrate solution, react at 37°C for 10 minutes. m After the reaction was stopped by adding L-chromogenic solution and the Fe complex was formed, the absorbance at 525 nm was measured. As a control, the absorbance of the sample solution after the reaction was similarly measured using a sample solution that had been heat-inactivated in advance, and the absorbance difference with the sample solution that had not been heat-inactivated was calculated. c -Monohydroxamic acid was used instead of the sample solution to prepare a standard curve, and the amount of hydroxamic acid generated by the absorbance difference was calculated. m One mol of hydroxamic acid is defined as 1 unit (1U) of enzyme activity.
[0087] The relative value (%) of the transglutaminase activity value after leaving the sample was calculated as the residual activity, with the transglutaminase activity value before leaving the sample to stand being 100%.
[0088] [Table 3]
[0089] As shown in Table 3, the activity stability of transglutaminase was improved simply by storing the liquid enzyme preparation containing transglutaminase in a container whose internal space was replaced with an inert gas.
[0090] [Test Example 4] Regarding the composition of the liquid enzyme preparation and whether the internal space of the container storing the liquid enzyme preparation was replaced with nitrogen, as shown in Tables 4A to 4D, the residual activity was measured in the same manner as in Test Example 3. The results are shown in Tables 4A to 4D.
[0091] [Table 4A]
[0092] [Table 4B]
[0093] [Table 4C]
[0094] [Table 4D]
[0095] As shown in Tables 4A to 4D, the enzyme activity stability of the liquid enzyme preparation containing transglutaminase contained in the container whose internal space is replaced with an inert gas is improved.
[0096] [Test Example 5] The residual activity was measured in the same manner as in Test Example 1 except that the composition of the liquid enzyme preparation, whether the internal space of the container storing the liquid enzyme preparation was replaced with nitrogen, and the storage conditions were as shown in Tables 5A to 5D. The results are shown in Tables 5A to 5D.
[0097] [Table 5A]
[0098] [Table 5B]
[0099] [Table 5C]
[0100] [Table 5D]
[0101] As shown in Tables 5A to 5D, the activity stability of the protein deamidase is improved by adding a predetermined additive to the liquid enzyme preparation containing the protein deamidase. Most of these predetermined additives are components known as antioxidants, but when other various known components known as antioxidants such as ascorbic acid are used, the effect of improving the activity stability of the protein deamidase cannot be obtained. In view of this, it can be seen that the effect of improving the activity stability of the above-mentioned protein deamidase is a unique effect caused by the use of the predetermined components.
Claims
1. A liquid enzyme preparation, characterized in that The liquid enzyme preparation contains an enzyme and is contained in a container whose internal space is replaced with an inert gas.
2. The liquid enzyme preparation according to claim 1, wherein The enzyme is a protein deamidase or a transglutaminase.
3. The liquid enzyme preparation according to claim 1, wherein The enzyme activity is 0.1U / ml to 10000U / ml.
4. The liquid enzyme preparation according to claim 1, wherein The liquid enzyme preparation comprises an additive selected from the group consisting of sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrate, polyphosphates, tartrates, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
5. A liquid enzyme preparation, characterized in that The liquid enzyme preparation comprises protein deamidase and an additive selected from the group consisting of sugar alcohols, glycerol, ethanol, sulfites, lecithin, citrate, polyphosphates, tartrates, phytic acid, metaphosphoric acid, sodium chloride, tocotrienols, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
6. The liquid enzyme preparation according to claim 4 or 5, wherein The total amount of the additives is 5 w / v% or more.
7. The liquid enzyme preparation according to claim 4 or 5, wherein The total amount of the additives is 80 w / v% or less.
8. The liquid enzyme preparation according to claim 1 or 5, wherein The pH of the liquid enzyme preparation is 5.5 or higher.
9. The liquid enzyme preparation according to claim 1 or 5, wherein The pH of the liquid enzyme preparation is below 8.
2.
10. The liquid enzyme preparation according to claim 5, wherein The protein deamidase activity is 0.1 U / ml to 10000 U / ml.
11. The liquid enzyme preparation according to claim 2 or 5, wherein The protein deamidase is derived from Chryseobacterium proteolyticus.
12. A method for stabilizing the enzyme activity of a liquid enzyme preparation, characterized in that: Containment: A liquid enzyme preparation containing an enzyme is stored in a container whose internal space is replaced with an inert gas.
13. A protein deamidase activity stabilizer for a liquid enzyme preparation containing a protein deamidase, characterized in that: The invention comprises an additive selected from the group consisting of sugar alcohol, glycerol, ethanol, sulfite, lecithin, citrate, polyphosphate, tartrate, phytic acid, metaphosphoric acid, sodium chloride, tocotrienol, methionine, pectin, beet pigment, capsicum pigment, rosemary extract, tocopherol, tea extract and butylated hydroxyanisole.
